Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?

Affiliations

¹ Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
² Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Editorial

Andrea Gini et al. Clin Gastroenterol Hepatol. 2022 Oct.

. 2022 Oct;20(10):2216-2217.

doi: 10.1016/j.cgh.2022.03.030. Epub 2022 Apr 4.

¹ Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
² Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

No abstract available

Comment on

Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study.
Baldacchini F, Bucchi L, Giuliani O, Mancini S, Ravaioli A, Vattiato R, Zamagni F, Giorgi Rossi P, Mangone L, Campari C, Sassatelli R, Trande P, Esposito P, Rossi F, Carrozzi G, Triossi O, Fabbri C, Strocchi E, Giovanardi M, Canuti D, Sassoli de Bianchi P, Ferretti S, Falcini F; Emilia-Romagna Region Workgroup for Colorectal Screening Evaluation. Baldacchini F, et al. Clin Gastroenterol Hepatol. 2022 Oct;20(10):2373-2382. doi: 10.1016/j.cgh.2022.01.053. Epub 2022 Feb 7. Clin Gastroenterol Hepatol. 2022. PMID: 35144023